InvestorsHub Logo
Followers 73
Posts 5804
Boards Moderated 0
Alias Born 12/02/2009

Re: Myth post# 64662

Monday, 01/08/2024 11:01:53 AM

Monday, January 08, 2024 11:01:53 AM

Post# of 65781
Tony Tontat:

Interview (formerly Kiromic/KMBP) April 13, 2021:

https://schwabnetwork.com/video/tony-tontat-talks-kiromic-biopharma-krbp-?redirect=true

https://www.linkedin.com/in/tony-tontat-49976/

On the Negative side...just doing some DD:

https://www.andrewjowett.net/2022/02/02/houston-biopharma-misled-investors-in-40-million-offering/

"For good measure, the Special Committee also found that Mr. Tontat lied to the company about his educational background. Instead of a BA in Economics from Harvard University, he received a Bachelor of Liberal Arts, a degree conferred by the Harvard Extension School.

Mr. Tontat resigned as CFO in October 2021, with Dan Clark, VP of Finance, promoted to interim CFO. The SEC filing announcing Mr. Tontat’s resignation stated that it was due to personal reasons and did not relate to any disagreement with the operations, policies or practices of the Company on any matters."

https://ir.kiromic.com/node/6941/html

https://www.nasdaq.com/press-release/kiromic-biopharma-announces-chief-financial-officer-transition-2021-10-05

"In a separate matter, on or about August 17 and 23, 2021, Tony Tontat, who at the time was the Chief Financial Officer and a member of the Board, submitted substantially identical reports (the “Complaints”) through the Company’s complaint hotline. These Complaints, alleged, among other topics, risks associated with the Company’s public disclosures in securities filings and in statements made to the public, investors, and potential investors regarding (i) the anticipated timing of the FDA authorization of the IND applications and (ii) the anticipated timing of human clinical trials. These Complaints were subsequently submitted to the Audit Committee of the Board.


After receiving the Complaints, the Audit Committee recommended that the Board form, and the Board did in turn form, a Special Committee comprised of three independent directors (the “Special Committee”) to review the Complaints and other related issues (the “Internal Review”). The Special Committee retained an independent counsel to assist it in conducting the Internal Review."

https://capedge.com/filing/1792581/0001558370-23-009941/KRBP-10Q-2023Q1

___
Kiromic (and Tony and other execs) appears to have had, and is having, some roller coaster moments, imo.
hL shmn